Plexus (PLXS) Reports Q2 Earnings: What Key Metrics Have to Say
Werte in diesem Artikel
For the quarter ended March 2025, Plexus (PLXS) reported revenue of $980.17 million, up 1.4% over the same period last year. EPS came in at $1.66, compared to $0.94 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $980.47 million, representing a surprise of -0.03%. The company delivered an EPS surprise of +7.79%, with the consensus EPS estimate being $1.54.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Plexus performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Market Sector- Healthcare/Life Sciences: $411 million versus the two-analyst average estimate of $407.10 million. The reported number represents a year-over-year change of +8.4%. Revenue- Market Sector- Aerospace/Defense: $172 million versus $174.10 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +1.2% change. Revenue- Market Sector- Industrial: $397 million versus $399.55 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -5% change. View all Key Company Metrics for Plexus here>>>Shares of Plexus have returned -6.1% over the past month versus the Zacks S&P 500 composite's -6.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Plexus Corp. (PLXS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Plexus und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Plexus
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Plexus
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Q2 Holdings Inc
Analysen zu Q2 Holdings Inc
Datum | Rating | Analyst | |
---|---|---|---|
13.08.2019 | Q2 Buy | Compass Point | |
01.03.2019 | Q2 Buy | Needham & Company, LLC | |
19.12.2018 | Q2 Buy | BTIG Research | |
09.08.2018 | Q2 Buy | Needham & Company, LLC | |
11.05.2018 | Q2 Neutral | BTIG Research |
Datum | Rating | Analyst | |
---|---|---|---|
11.05.2018 | Q2 Neutral | BTIG Research | |
18.11.2016 | Q2 Sector Weight | Pacific Crest Securities Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Q2 Holdings Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen